| Attributes | Values |
|---|
| rdf:type
| |
| description
| - artículu científicu espublizáu en 2003 (ast)
- vědecký článek publikovaný v roce 2003 (cs)
- 2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած (hyw)
- наукова стаття, опублікована в листопаді 2003 (uk)
- 2003 թվականի նոյեմբերին հրատարակված գիտական հոդված (hy)
- مقالة علمية (نشرت في 14-11-2003) (ar)
- vedecký článok (publikovaný 2003/11/14) (sk)
- wetenschappelijk artikel (gepubliceerd op 2003/11/14) (nl)
- im November 2003 veröffentlichter wissenschaftlicher Artikel (de)
- article publié dans la revue scientifique Journal of Biological Chemistry (fr)
- scientific journal article (en)
|
| publication date
| |
| publication date
| |
| language of work or name
| |
| language of work or name
| |
| author name string
| |
| author name string
| - Hong Gao
- George H. Searfoss
- Patrick C. May
- Brian R. Berridge
- David O. Calligaro
- Elizabeth J. Galbreath
- Linda M. Schirtzinger
- Marnie A. Higgins
- Timothy P. Ryan
- William H. Jordan
|
| rdfs:label
| - Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional gamma-secretase inhibitor (en)
- Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional gamma-secretase inhibitor (nl)
- Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional gamma-secretase inhibitor (ast)
|
| skos:prefLabel
| - Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional gamma-secretase inhibitor (en)
- Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional gamma-secretase inhibitor (nl)
- Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional gamma-secretase inhibitor (ast)
|
| name
| - Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional gamma-secretase inhibitor (en)
- Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional gamma-secretase inhibitor (nl)
- Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional gamma-secretase inhibitor (ast)
|
| title
| |
| title
| - Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional gamma-secretase inhibitor (en)
|
| page(s)
| |
| page(s)
| |
| instance of
| |
| instance of
| |
| main subject
| |
| main subject
| |
| PubMed ID
| |
| PubMed ID
| |
| PubMed ID
| |
| published in
| |
| published in
| |
| issue
| |
| volume
| |
| issue
| |
| volume
| |
| DOI
| |
| DOI
| |
| DOI
| |
| Fatcat ID
| |
| Fatcat ID
| - release_m4brysew7bg4dpmbrzvbqgsepa
|
| is about
of | |
| is cites work
of | - Vital roles of mTOR complex 2 in Notch-driven thymocyte differentiation and leukemia
- Intra- or intercomplex binding to the gamma-secretase enzyme. A model to differentiate inhibitor classes
- The impact of surfactant protein-A on ozone-induced changes in the mouse bronchoalveolar lavage proteome.
- Pharmacologic blockade of 5-lipoxygenase improves the amyloidotic phenotype of an Alzheimer's disease transgenic mouse model involvement of γ-secretase
- Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update
- The large hydrophilic loop of presenilin 1 is important for regulating gamma-secretase complex assembly and dictating the amyloid beta peptide (Abeta) Profile without affecting Notch processing
- Gamma-secretase inhibitor treatment promotes VEGF-A-driven blood vessel growth and vascular leakage but disrupts neovascular perfusion
- Tips, stalks, tubes: notch-mediated cell fate determination and mechanisms of tubulogenesis during angiogenesis
- Notch dimerization is required for leukemogenesis and T-cell development
- Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis
- Treatment strategies targeting amyloid β-protein
- Notch signaling in solid tumors.
- Notch inhibits expression of the Krüppel-like factor 4 tumor suppressor in the intestinal epithelium
- Presenilins: members of the gamma-secretase quartets, but part-time soloists too.
- gamma-secretases: from cell biology to therapeutic strategies
- Presenilins and γ-secretase: structure, function, and role in Alzheimer Disease
- Transcriptional regulation of human FE65, a ligand of Alzheimer's disease amyloid precursor protein, by Sp1
- Chronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation
- Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia
- Direct regulation of intestinal fate by Notch
- NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts
- Structure, mechanism and inhibition of gamma-secretase and presenilin-like proteases
- Amyloid beta-protein precursor juxtamembrane domain regulates specificity of gamma-secretase-dependent cleavages
- Therapeutic targeting of NOTCH1 signaling in T-cell acute lymphoblastic leukemia
- Mir-206 regulates pulmonary artery smooth muscle cell proliferation and differentiation
- Inhibition and modulation of gamma-secretase for Alzheimer's disease
- Cellular and molecular mechanisms of the epithelial repair in IBD.
- Intramembrane proteolysis
- The structure and function of Alzheimer's gamma secretase enzyme complex.
- Targeting Abeta and tau in Alzheimer's disease, an early interim report
|
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)